Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B.
JGH open : an open access journal of gastroenterology and hepatology(2023)
摘要
Switching from ETV to TAF increases the CVR rate in patients with LLV or occasional detectable HBV DNA and could be an alternative treatment option.
更多查看译文
关键词
chronic hepatitis,tenofovir alafenamide,entecavir,virological response,complete virological response
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要